InvestorsHub Logo

biosectinvestor

01/21/22 3:22 PM

#437526 RE: W_W #437523

Using 5% floor space of their factory and only for compassionate use, using their legacy hand made technology used for the clinical trials in that space. Their machines likely take up far less space than the clean rooms and as they were at the acquisition, made for small labs, they make 10 times the production per clean room. So the potential to scale is immense, and would likely improve over time as they go from machines to a full scale production facility that is totally automated, but the company will likely be sold and not have to scale that up beyond the many tens of thousands of doses they could likely make if they scaled up just this or facility even just with individual machines, though I think long-term they’d turn the facility into one giant “machine” with parallel processing of doses, using the space and technology more efficiently.

I think you do not understand this yet.

wimike

01/21/22 3:52 PM

#437544 RE: W_W #437523

I have the same problem seeing where all these 100's of millions of revenue will come from. But yet people here say selling prices at high as $250'share-WOOW. That would be a HIGHER MC than Merck, but who is to say these geniuses are wrong, NOT So how do we do it alone?
I would take $5/share before the close today and AMEN.
You have to realize $5/share is over 600% of the price right now. Who buys out a company for a 600% Premium?

I want to smoke what everyone else is smoking here.




SHOW ME THE MONEY